세계의 갱년기 장애 시장 보고서(2025년)

Menopause is a natural biological process signifying the cessation of a woman's menstrual cycles and reproductive years, officially diagnosed when there is a 12-month absence of a menstrual period. This phase is characterized by various physical and hormonal changes, denoting the conclusion of reproductive capabilities as the ovaries cease egg release, and the hormones progesterone and estrogen decline.

The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The menopause market research report is one of a series of new reports from The Business Research Company that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The menopause market size has grown strongly in recent years. It will grow from $17.74 billion in 2024 to $18.78 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased life expectancy, women's health awareness, nutritional supplements, healthcare access improvement, stress and lifestyle management, patient advocacy.

The menopause market size is expected to see strong growth in the next few years. It will grow to $24.29 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of hormone replacement therapy (HRT) patches and bioidentical progesterone sourced from Canada and France, thereby limiting treatment accessibility and elevating gynecological care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising physical inactivity among women is anticipated to boost the growth of the menopause market in the coming years. Physical inactivity, defined as minimal engagement in physical movement-whether during leisure, commuting, or daily tasks-has been linked to worsened menopausal symptoms and increased health risks. This trend has heightened the demand for products and services that help manage menopause-related health issues and support women's overall well-being. For example, in June 2024, the World Health Organization (WHO) reported that 27% of adults globally were physically inactive in 2022, with this figure expected to reach 35% by 2030. Consequently, the need for targeted solutions in the menopause market continues to grow, driven by the lifestyle and health challenges associated with reduced physical activity among women.

The shift toward healthier lifestyle choices is expected to drive the growth of the menopause market. Lifestyle changes, such as adopting balanced diets, regular exercise, better sleep, reduced alcohol intake, and engaging in stress-relieving activities, can help alleviate menopausal symptoms and promote overall well-being during this natural biological phase. Many women are increasingly focusing on lifestyle adjustments to manage menopause effectively, reflecting a broader trend toward wellness. For instance, a November 2023 report by the Global Wellness Institute, a U.S.-based organization, noted that in 2022, the wellness economy accounted for 5.6% of global economic output, with projections indicating it could grow to $8.5 trillion by 2027 at an average annual growth rate of 8.6%. This trend toward wellness-focused lifestyles is fueling the demand for menopause-related products and services.

Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.

In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.

Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC

North America was the largest region in the menopause market in 2024. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopause Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on menopause market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopause ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The menopause market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Dietary Supplements; Over-The-Counter (OTC) Pharma Products
• 2) By Route Of Administration: Topical; Oral; Injectables
• 3) By Distribution Channel: Hospital; Retail; Online Pharmacies
• 4) By End User: Hospital; Diagnostic Centers; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Dietary Supplements: Herbal Supplements; Vitamins And Minerals; Phytoestrogens; Omega-3 Fatty Acids; Probiotics
• 2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT); Non-Hormonal OTC Products; Antidepressants for Mood Swings; Sleep Aids; Pain Relievers
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc; The Procter & Gamble Company; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A; Abbott Laboratories Ltd.; GSK plc; Eli Lilly and Company; Amgen Inc.; Novo Nordisk A/S; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Sun Pharmaceutical Industries Limited; Cipla Inc.; Dr. Reddy's Laboratories Ltd.; Apotex Inc.; Rainbow Light Nutritional Systems LLC; Mithra Pharmaceuticals SA; TherapeuticsMD Inc.; Theramex SpA; Pure Encapsulations LLC.; Mylan N.V.; PADAGIS LLC; Serenity Pharmaceuticals LLC; ASCEND Therapeutics US LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Menopause Market Characteristics

3. Menopause Market Trends And Strategies

4. Menopause Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Menopause Growth Analysis And Strategic Analysis Framework

• 5.1. Global Menopause PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Menopause Market Growth Rate Analysis
• 5.4. Global Menopause Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Menopause Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Menopause Total Addressable Market (TAM)

6. Menopause Market Segmentation

• 6.1. Global Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Supplements
• Over-The-Counter (OTC) Pharma Products
• 6.2. Global Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• Injectables
• 6.3. Global Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Retail
• Online Pharmacies
• 6.4. Global Menopause Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Centers
• Specialty Clinics
• Other End Users
• 6.5. Global Menopause Market, Sub-Segmentation Of Dietary Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Supplements
• Vitamins And Minerals
• Phytoestrogens
• Omega-3 Fatty Acids
• Probiotics
• 6.6. Global Menopause Market, Sub-Segmentation Of Over-The-Counter (OTC) Pharma Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Replacement Therapy (HRT)
• Non-Hormonal OTC Products
• Antidepressants for Mood Swings
• Sleep Aids
• Pain Relievers

7. Menopause Market Regional And Country Analysis

• 7.1. Global Menopause Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Menopause Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Menopause Market

• 8.1. Asia-Pacific Menopause Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Menopause Market

• 9.1. China Menopause Market Overview
• 9.2. China Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Menopause Market

• 10.1. India Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Menopause Market

• 11.1. Japan Menopause Market Overview
• 11.2. Japan Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Menopause Market

• 12.1. Australia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Menopause Market

• 13.1. Indonesia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Menopause Market

• 14.1. South Korea Menopause Market Overview
• 14.2. South Korea Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Menopause Market

• 15.1. Western Europe Menopause Market Overview
• 15.2. Western Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Menopause Market

• 16.1. UK Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Menopause Market

• 17.1. Germany Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Menopause Market

• 18.1. France Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Menopause Market

• 19.1. Italy Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Menopause Market

• 20.1. Spain Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Menopause Market

• 21.1. Eastern Europe Menopause Market Overview
• 21.2. Eastern Europe Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Menopause Market

• 22.1. Russia Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Menopause Market

• 23.1. North America Menopause Market Overview
• 23.2. North America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Menopause Market

• 24.1. USA Menopause Market Overview
• 24.2. USA Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Menopause Market

• 25.1. Canada Menopause Market Overview
• 25.2. Canada Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Menopause Market

• 26.1. South America Menopause Market Overview
• 26.2. South America Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Menopause Market

• 27.1. Brazil Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Menopause Market

• 28.1. Middle East Menopause Market Overview
• 28.2. Middle East Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Menopause Market

• 29.1. Africa Menopause Market Overview
• 29.2. Africa Menopause Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Menopause Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Menopause Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Menopause Market Competitive Landscape And Company Profiles

• 30.1. Menopause Market Competitive Landscape
• 30.2. Menopause Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Menopause Market Other Major And Innovative Companies

• 31.1. AbbVie Inc.
• 31.2. Bayer AG
• 31.3. Novartis AG
• 31.4. Sanofi S.A
• 31.5. Abbott Laboratories Ltd.
• 31.6. GSK plc
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Novo Nordisk A/S
• 31.10. Viatris Inc.
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Astellas Pharma Inc.
• 31.13. Sun Pharmaceutical Industries Limited
• 31.14. Cipla Inc.
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Menopause Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Menopause Market

34. Recent Developments In The Menopause Market

35. Menopause Market High Potential Countries, Segments and Strategies

• 35.1 Menopause Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Menopause Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Menopause Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer